Pirouette Pharma Analysis: $6M Raised
What is Pirouette Pharma?
Pirouette Pharma develops innovative healthcare solutions, focusing on advanced drug delivery systems and therapies to enhance patient care and improve lives.
Employees
9
Founded
2017
Investors
- Safar Partners
- Y Combinator
Product Features & Capabilities
- Emergency auto-injector for severe allergic reactions, potential for opioid overdose treatment, advanced drug delivery systems.
How much Pirouette Pharma raised
Community Round (not specified) - $6,049,106
Closing on March 13, 2024Lead Investor: 3,898 investors, backed by Y Combinator, Safar Partners, Liquid 2 Ventures, Gaingels
Who are the founders of Pirouette Pharma
Market Focus
Pirouette Pharma primarily focuses on the healthcare industry, specifically in developing innovative healthcare solutions, including advanced drug delivery systems and therapies aimed at enhancing patient care and improving lives.
Competitors Overview
Pirouette Pharma operates in the pharmaceutical drug delivery market, which is highly competitive. Key competitors include:
- Bayer AG: Known for its extensive research and development capabilities, Bayer focuses on innovative drug delivery systems and has a strong presence in various therapeu
See something that needs updating? Suggest edits to this profile.